HDAC inhibitors have been demonstrated to improve memory retention in an Alzheimer’s disease model utilizing APP/PS1 mice (Saha and Pahan, 2006). This evidence concerns the gene HDAC9 and early-onset autosomal dominant Alzheimer disease.